Exclusive

Publication

Byline

University of Melbourne and IISER Tirupati expand partnership to deliver world-class research education

Singapore, Oct. 13 -- The University of Melbourne, Australia and the Indian Institute of Science Education and Research (IISER) Tirupati have deepened their partnership, launching a new dual degree to... Read More


Singapore's NTU and Boehringer Ingelheim collaborate to explore new approaches for treating obesity

Singapore, Oct. 13 -- Nanyang Technological University (NTU), Singapore and global biopharmaceutical company Boehringer Ingelheim will be investigating new approaches to treating obesity, following a ... Read More


Americhem opens new clean compounding facility in Suzhou, China

Singapore, Oct. 13 -- Americhem, a global leader in custom polymer solutions, recently celebrated the opening of its new clean compounding facility in Suzhou. The investment expands Americhem's abilit... Read More


Ultrahuman and Abu Dhabi Public Health Centre partner to build Biological Age model

Singapore, Oct. 13 -- The Abu Dhabi Public Health Centre (ADPHC) has signed a strategic Memorandum of Understanding (MoU) with Ultrahuman Healthcare SP LLC, a global health technology company and TIME... Read More


Korea's GCCL signs MoU with LabConnect to expand global clinical trial collaboration

Singapore, Oct. 13 -- GCCL, a South Korea-based leading global clinical trial central laboratory, has signed a Memorandum of Understanding (MoU) with US-based LabConnect, to expand global clinical tri... Read More


Australia's Firebrick Pharma secures $732k in strategic investments

Singapore, Oct. 12 -- Australia-based Firebrick Pharma has secured firm commitments from strategic investors for approximately $732k, through the placement of approximately 20.9 million fully paid ord... Read More


Philanthropy Asia Alliance backs Southeast Asia Heat Health Hub's next phase

Singapore, Oct. 12 -- The Philanthropy Asia Alliance (PAA) has announced its support for the next stage of the Global Heat Health Information Network (GHHIN) Southeast Asia Hub at the Global Heat Foru... Read More


Foresee Pharma announces China NMPA approval of CAMCEVI(R) 42 mg for treatment of advanced prostate cancer

Singapore, Oct. 12 -- Taiwan-based Foresee Pharmaceuticals has been notified by its licensing partner, Changchun GeneScience Pharmaceutical (GenSci), that China's National Medical Products Administrat... Read More


Korea's Lunit collaborates with US-based Discovery Life Sciences to expand AI-powered tissue analysis for biopharma research

Singapore, Oct. 12 -- South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a strategic collaboration with Discovery Life Sciences, a global le... Read More


Everest Medicines announces NMPA acceptance of LEROCHOL BLA for hypercholesterolemia

Singapore, Oct. 12 -- Everest Medicines announced on June 26, 2026, that China's National Medical Products Administration (NMPA) accepted the Biologics License Application (BLA) for LEROCHOL (lerodalc... Read More